These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20074047)

  • 1. Strategies for the identification of ubiquitin ligase inhibitors.
    Goldenberg SJ; Marblestone JG; Mattern MR; Nicholson B
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):132-6. PubMed ID: 20074047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for the identification of novel inhibitors of deubiquitinating enzymes.
    Goldenberg SJ; McDermott JL; Butt TR; Mattern MR; Nicholson B
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):828-32. PubMed ID: 18793145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patent review of the ubiquitin ligase system: 2015-2018.
    Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
    Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies within the ubiquitin proteasome system.
    Eldridge AG; O'Brien T
    Cell Death Differ; 2010 Jan; 17(1):4-13. PubMed ID: 19557013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.
    Landré V; Rotblat B; Melino S; Bernassola F; Melino G
    Oncotarget; 2014 Sep; 5(18):7988-8013. PubMed ID: 25237759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitination and deubiquitination: Implications on cancer therapy.
    Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin system, disease, and drug discovery.
    Petroski MD
    BMC Biochem; 2008 Oct; 9 Suppl 1(Suppl 1):S7. PubMed ID: 19007437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
    Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
    Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the ubiquitin system in cancer therapy.
    Hoeller D; Dikic I
    Nature; 2009 Mar; 458(7237):438-44. PubMed ID: 19325623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discovery in the ubiquitin-proteasome system.
    Nalepa G; Rolfe M; Harper JW
    Nat Rev Drug Discov; 2006 Jul; 5(7):596-613. PubMed ID: 16816840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-protein ligases--novel therapeutic targets?
    Robinson PA; Ardley HC
    Curr Protein Pept Sci; 2004 Jun; 5(3):163-76. PubMed ID: 15180521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-proteasome system as a target for anticancer treatment-an update.
    Kim YJ; Lee Y; Shin H; Hwang S; Park J; Song EJ
    Arch Pharm Res; 2023 Jul; 46(7):573-597. PubMed ID: 37541992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment.
    Park J; Cho J; Song EJ
    Arch Pharm Res; 2020 Nov; 43(11):1144-1161. PubMed ID: 33165832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patented small molecule inhibitors in the ubiquitin proteasome system.
    Guédat P; Colland F
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S14. PubMed ID: 18047738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deubiquitylating enzymes and drug discovery: emerging opportunities.
    Harrigan JA; Jacq X; Martin NM; Jackson SP
    Nat Rev Drug Discov; 2018 Jan; 17(1):57-78. PubMed ID: 28959952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic potential of deubiquitinating enzyme inhibitors.
    Colland F
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):137-43. PubMed ID: 20074048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-proteasome system and cardiovascular disease.
    Powell SR; Herrmann J; Lerman A; Patterson C; Wang X
    Prog Mol Biol Transl Sci; 2012; 109():295-346. PubMed ID: 22727426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases.
    Edelmann MJ; Nicholson B; Kessler BM
    Expert Rev Mol Med; 2011 Nov; 13():e35. PubMed ID: 22088887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discovery and assay development in the ubiquitin-proteasome system.
    Berkers CR; Ovaa H
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):14-20. PubMed ID: 20074028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.